D4DPR believes that it is important to understand the limited effect that rescheduling will have on the clinical practice of cannabis medicine, the criminalization of cannabis cultivation/production, sale and use, and research. In our new policy paper “The Importance of Descheduling, Not Just Rescheduling, Cannabis in the U.S.,” (modeled after our recent letter to the White House), we highlight and address some of the significant limitations associated with rescheduling and the need to federally deschedule cannabis from the Controlled Substances Act (CSA).